The University of Chicago Header Logo

Connection

Ross Kopher to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications Ross Kopher has written about TOR Serine-Threonine Kinases.
Ross Kopher
Connection Strength
0.193
TOR Serine-Threonine Kinases
  1. Assessments of prostate cancer cell functions highlight differences between a pan-PI3K/mTOR inhibitor, gedatolisib, and single-node inhibitors of the PI3K/AKT/mTOR pathway. Mol Oncol. 2025 Jan; 19(1):225-247.
    View in: PubMed
    Score: 0.193
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.